November 18, 2024

Addressing Barriers to Adoption of AI in DR Screening

OCT imaging was applied in 80.3% of imaging cases, despite high sensitivity and specificity of FDA-approved AI tools.

Conexiant

November 18, 2024

Study Links Coffee Timing to Mortality Risk in Diabetes

A temporal link between coffee timing and mortality reveals that drinking coffee between 5:00-8:00 AM was associated with a 41% higher risk of cardiovascular mortality in patients with diabetes, while consumption between 8:00 AM-noon reduced risk by 21%.

Conexiant

November 14, 2024

800M Adults Have Diabetes, Many Untreated: Study

Reuters

November 08, 2024

Is Intravenous Methylprednisolone Efficacious for Visual Complications of GCA?

While timely treatment is essential to protect vision, the researchers found no visual acuity benefit with IVMP.

Conexiant

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

June 06, 2024

U.S. FDA Halts Biomea's Diabetes Trial

Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.

Reuters

July 03, 2024

Semaglutide Linked to Vision-Threatening Eye Disorder

New study finds that 8.9% of type 2 diabetes patients taking semaglutide experienced NAION, compared to 1.8% of those on non-GLP-1 diabetes drugs.

Reuters

June 26, 2024

Daily Multivitamin Use: No Mortality Benefit Found

"In contrast, we found that daily multivitamin use vs. nonuse was associated with 4% higher mortality risk."

Conexiant